![]() ![]() ![]() In certain embodiments, the cancer is relapsed or refractory Hodgkin lymphoma, including relapsed or refractory Hodgkin lymphoma in a patient who has failed brentuximab vedotin and a PD-1 inhibitor, relapsed or refractory T-cell non-Hodgkin lymphoma, relapsed or refractory Burkitt's lymphoma, or high-grade B-cell lymphoma with rearrangements of MYC and BCL2 and/or BCL6. In certain embodiments, the cancer is not a cancer of the pancreas or a cancer of the prostate. The cancer may be, for example, a lymphoma, leukemia, carcinoma, sarcoma, myeloma, brain or spinal cord cancer, melanoma, blastoma, germ cell tumor, cancer of the pancreas, or cancer of the prostate. In certain embodiments, the disease or disorder may be a cancer, which may be, for example, relapsed or refractory. In certain embodiments, the disease or disorder is not a cancer of the pancreas or a cancer of the prostate. The invention provides methods and compositions for treating a disease or disorder by orally administering 6,8-bis-benzylthio-octanoic acid or a pharmaceutically acceptable salt thereof to a patient in need of such treatment. ![]()
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |